Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...